SBI Securities’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343 Sell
5
-2
-29% -$114 ﹤0.01% 3161
2026
Q1
$450 Sell
7
-4
-36% -$365 ﹤0.01% 2924
2025
Q4
$1.43K Sell
11
-101
-90% -$13.9K ﹤0.01% 2513
2025
Q3
$12.1K Buy
112
+95
+559% +$10.3K ﹤0.01% 1688
2025
Q2
$1.57K Sell
17
-30
-64% -$2.35K ﹤0.01% 2497
2025
Q1
$4.16K Buy
47
+32
+213% +$2.78K ﹤0.01% 1969
2024
Q4
$1.15K Buy
+15
New +$1.05K ﹤0.01% 2544

Other funds holding WGS

SBI Securities's WGS Position: Q2 2026 in Review

SBI Securities reduced its GeneDx Holdings (WGS) stake by 29% in Q2 2026, selling an estimated $114 and leaving 5 shares worth $343. The position accounts for ﹤0.01% of the portfolio, ranked #3161.

SBI Securities first reported a position in WGS in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.1K in Q3 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • SBI Securities held 5 shares of GeneDx Holdings worth $343 as of Q2 2026.
  • SBI Securities sold 2 GeneDx Holdings shares in Q2 2026, an estimated $114.
  • GeneDx Holdings made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3161 holding.
  • SBI Securities first reported a position in GeneDx Holdings in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's GeneDx Holdings position peaked at $12.1K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.